Bloodstream infections can progress rapidly to sepsis—bringing high costs, high mortality, and lasting effects. In the second episode of this series in collaboration with bioMérieux, Luis speaks with Dr. Jeff Cies, Senior Medical Advisor at bioMérieux, about how molecular diagnostics are reshaping bloodstream infection diagnosis.
They discuss:
Limitations of traditional blood cultures
How rapid molecular tests deliver results faster than ever
The impact on outcomes, costs, and antimicrobial resistance
The role of stewardship programs in maximizing results
What the future holds: direct-from-blood testing, nanotechnology, and AI
A powerful look at how innovation in microbiology is changing the fight against sepsis and saving lives.
This episode is sponsored by bioMérieux, a global innovator in infectious disease diagnostics.
Resources from this episode:
Stay connected with Let's Talk Micro:
Website: letstalkmicro.com
Questions or feedback? Email me at letstalkmicro@outlook.com
Support the podcast:
